Isolated Heart Preparation
"Isolated Heart Preparation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Method of isolation and maintenance of a working heart for various cardiac measurements. The model allows for the separation of cardiac and systemic variables in the denervated heart.
| Descriptor ID |
D000067268
|
| MeSH Number(s) |
E05.519 E05.598.750
|
| Concept/Terms |
Isolated Heart Preparation- Isolated Heart Preparation
- Isolated Heart Preparations
- Preparation, Isolated Heart
- Preparations, Isolated Heart
- Isolated Perfused Heart Model
Langendorff Perfused Heart- Langendorff Perfused Heart
- Heart, Langendorff Perfused
- Perfused Heart, Langendorff
- Langendorff Perfused Isolated Heart Preparation
Working Heart Preparation- Working Heart Preparation
- Preparation, Working Heart
- Preparations, Working Heart
- Working Heart Preparations
- Working Heart Technique
- Technique, Working Heart
- Techniques, Working Heart
- Working Heart Techniques
|
Below are MeSH descriptors whose meaning is more general than "Isolated Heart Preparation".
Below are MeSH descriptors whose meaning is more specific than "Isolated Heart Preparation".
This graph shows the total number of publications written about "Isolated Heart Preparation" by people in this website by year, and whether "Isolated Heart Preparation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Isolated Heart Preparation" by people in Profiles.
-
Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes. Cardiovasc Res. 2024 10 14; 120(12):1456-1471.
-
Intracellular sodium elevation reprograms cardiac metabolism. Nat Commun. 2020 08 28; 11(1):4337.
-
Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors. Cardiovasc Res. 2019 03 01; 115(3):556-569.
-
Leadless multisite pacing: A feasibility study using wireless power transfer based on Langendorff rodent heart models. J Cardiovasc Electrophysiol. 2018 11; 29(11):1588-1593.
-
AMP-activated protein kinase protects against necroptosis via regulation of Keap1-PGAM5 complex. Int J Cardiol. 2018 05 15; 259:153-162.
-
Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol. 2018 04 01; 314(4):H812-H838.
-
Reversible redox modifications of ryanodine receptor ameliorate ventricular arrhythmias in the ischemic-reperfused heart. Am J Physiol Heart Circ Physiol. 2016 09 01; 311(3):H713-24.